LEO Pharma

LEO Pharma is a leader in medical dermatology with a robust R&D pipeline across a wide range of therapies enabling people with severe skin diseases to access medicine and treatment.

Company Background

• Advancing the science of dermatology with a leading branded topical dermatology franchise based on decades of research and development.
• Setting new standards of care for people with skin conditions with a global team serving millions of patients across the world.

Vision & Outlook

• Support LEO Pharma on its journey to strengthening its global leadership in medical dermatology.
• Help to expand the company's dermatology franchise and to accelerate innovation and growth.

Highlights & Updates

• Launched ESG-linked financing.
• In 2023, Leo Pharma signed an agreement to acquire Timber Pharmaceutical. Adding an attractive late-stage asset to LEO Pharma’s pipeline. The acquisition was finalised in 2024.
• In 2024, Leo Pharma committed to net-zero greenhouse gas emissions by 2050 by the Science Based Target Initiative (SBTi).